Understanding uterine cancer research studies
Part of Cancer, Women’s health & pregnancy clinical trials.
This study looks at why people with uterine cancer choose to join clinical trials. It aims to make future research easier and better informed.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have been diagnosed with uterine cancer
- You have not had any treatment yet for your uterine cancer
- You can understand and sign a consent form
- You are not currently in another research study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is looking at women who have unusual bleeding or bleeding after menopause to find better ways to diagnose reproductive cancers like endometrial cancer. If you are 45 or older and still have your uterus, you may be able to help.
This study collects blood and tumor tissue samples from patients with certain untreated cancers to help researchers develop and improve tests. You may be eligible if you have one of the listed cancer types and have not yet started treatment.
This study looks at how people with endometrial cancer manage their care and treatment. It aims to understand your experiences to help improve support for others.
This study looks at how people with bladder cancer decide to join clinical trials. You may help researchers understand what matters most to patients like you.
This trial studies how people with kidney cancer decide to join clinical studies. It looks at trends in participation to help make future studies better.
This study asks people with rectal cancer to share their experiences in clinical trials. It may help researchers understand what patients go through, and could improve how future rectal cancer studies are designed.
Hear when a new Uterine Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.